|
| Author(s) | Genetic variants |
|
|
Treloar et al., 2005 [53]
| Significant linkage on chromosome 10q26 and chromosome 20p13 |
|
| Singh et al., 2008 [54] | Upregulation of dioxin-inducible CYP1A1 and gamma-SYN and of Estrogen Receptor |
|
| Wu et al., 2012 [55] | Polymorphisms of dioxin receptor complex components and detoxification-related genes |
|
| Vichi et al., 2012 [56] | GSTP1(Ile/Ile) and GSTM1 null genotypes, modulating the effect of PCB153, PCB180, and of total PCBs |
|
|
Painter et al., 2011 [57]
| rs11592737 in the cytochrome P450 subfamily C (CYP2C19) |
|
| Costa et al., 2011 [58] | PROGINS polymorphisms (A1/A1, A1/A2 and A2/A2) |
|
| Govatati et al., 2012 [59] | E-cadherin −347GA/GA and −160A/A genotypes and −347GA/−160A/+54C and −347G/−160A/+54C haplotypes |
|
| Guo, 2006 [60] | CYP17, CYP19, Androgen Receptor, Progesterone Receptor, and Estrogen Receptor genetic variants are not associated with endometriosis |
|
| Kim et al., 2011 [61] | IGF-II 820G>A polymorphism |
|
| Kim et al., 2012 [62] | AAG haplotype allele of the −672A>G, −202A>C and c.95C>G polymorphisms in the IGFBP3 |
|
| Çayan et al., 2010 [63] | IRS2 G1057D polymorphism |
|
| Ammendola et al., 2008 [64] | PTPN22T variant |
|
| Lee et al., 2009 [65] | C627T polymorphism of the IL-2R beta |
|
| Gonçalves-Filho et al., 2011 [66] | PAI-1 4G/5G polymorphism |
|
| André et al., 2011 [67] | FOXP3 polymorphisms (rs3761549) |
|
| Barbosa et al., 2012 [68] | Allele FOXP3 T for genotypes FCRL3TT/FOXP3CT, FCRL3CT/FOXP3CT, FCRL3CC/FOXP3CT |
|
| Ruiz et al., 2011 [69] | Variants in LOXL4 and complement C3 |
|
| Medeiros et al., 2012 [70] | HMGA rearrangements |
|
| Nyholt et al., 2012 [71] | WNT4, VEZT, GREB1 polymorphism |
|
